|
||||
2022-08-11 10:30:00 CEST 2022-08-11 10:30:00 CEST Orion - Managers' transactionsOrion Corporation: Managers' transactions - Satu AhomäkiORION CORPORATION Orion Corporation: Managers’ transactions – Satu Ahomäki Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons. Orion Oyj - Managers' Transactions Person subject to the notification requirement Issuer: Orion Oyj Transaction date: 2022-08-10 Transaction details Aggregated transactions Orion Corporation
Publisher: Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are neurological disorders, oncology and respiratory diseases for which Orion develops inhaled pulmonary medication. Orion's net sales in 2021 amounted to EUR 1,041 million and the company had about 3,350 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki. |
||||
|